Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency

Journal of Bone and Mineral Research

Volumn 13, Issue 2, 1998, Pages 245-252

  De Boer, Hans ^a,b   Blok, Geert Jan ^a   Popp Snijders, Corrie ^a   Sips, Adriënne ^a   Lips, Paul ^a   Van Der Veen, Eduard ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Infection and Immunology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM 45; COLLAGEN TYPE 1; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; PROCOLLAGEN; STRONTIUM CHLORIDE; TESTOSTERONE UNDECANOATE; VASOPRESSIN;

ADULT; ARTICLE; BONE METABOLISM; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INTESTINE ABSORPTION; MALE; TREATMENT OUTCOME;

EID: 0031894444     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.2.245     Document Type: Article

References (44)

1. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118-123.
2. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348.
3. De Boer H, Blok GJ, van Lingen A, Teule GJJ, Lips P, van der Veen EA 1994 Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 9:1319-1326.
4. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Vogt TM 1993 Bone density at various sites for prediction of hip fractures. Lancet 341:72-75.
5. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL 1993 Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 8: 1227-1233.
6. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ 1980 Bone mineral status in growth hormone deficiency. J Pediatr 96:393-396.
7. Zamboni G, Antoniazzi F, Radetti G, Musumeci G, Tato L 1991 Effects of two different regimens of recombinant human growth hormone on the bone mineral density of patients with growth hormone deficiency. J Pediatr 119:483-485.
8. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G 1993 Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122:37-45.
9. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S 1996 The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency: Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 81:3077-3083.
10. Delmas PD, Chatelain P, Malaval L, Bonne G 1986 Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res 4:333-338.
11. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachmann M, Christiansen C 1990 Serum bone GLA protein: A potential marker of growth hormone deficiency and the response to GH therapy. J Clin Endocrinol Metab 71:122-126.
12. Sartorio A, Conti A, Monzani M 1993 New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad Med J 69:846-850.
13. Carey DE, Goldberg B, Ratzan SK, Rubin KR, Rowe DW 1985 Radioimmunoassay for type I procollagens in growth hormone deficient children before and during treatment with growth hormone. Pediatr Res 19:8-11.
14. Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CGD, Mowat AP 1991 Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 30:276-280.
15. Kubo T, Tanaka H, Inoue M, Kanzaki S, Seino Y 1995 Serum levels of carboxyterminal propeptide of type I procollagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Bone 17:397-401.
16. Johansen J, Pedersen SA, Jorgensen JOL, Riis BJ, Christiansen C, Christiansen JS, Skakkebaek NE 1990 Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab 70:916-919.
17. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JOL, Hassager C, Christiansen C 1991 The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol 35:471-476.
18. Balducci R, Toscano V, Pasquino AM, Mangiantini A, Municchi G, Armenise P, Terracina S, Prossomariti G, Boscherini B 1995 Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. Eur J Endocrinol 132:42-46.
19. Sherman SS, Hollis BW, Tobin JD 1990 Vitamin D status and related parameters in a healthy population: The effects of age, sex and season. J Clin Endocrinol Metab 71:405-413.
20. Sips AJAM, Netelenbos JC, Barto R, Lips P, van der Vijgh 1994 One hour test for estimating intestinal absorption of calcium by using stable strontium as a marker. Clin Chem 40:257-259.
21. Sips AJAM, van der Vijgh WJF, Barto R, Netelenbos JC 1995 Intestinal strontium absorption: from bioavailability to validation of a simple test representative for intestinal calcium absorption. Clin Chem 41:1446-1450.
22. Sips AJAM, Barto R, Netelenbos JC, van der Vijgh WJF 1997 Preclinical screening of the applicability of strontium as a marker for intestinal calcium absorption. Am J Physiol 272:E422-E428.
23. De Boer H, Blok GJ, Voerman HJ, de Vries PMJM, van der Veen EA 1992 Body composition in adult growth hormone deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab 75:833-837.
24. Rosen T, Bosaeus I, Tölli J, Lindstedt G, Bengtsson BA 1993 Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol 38:63-71.
25. De Boer H, Blok GJ, Voerman B, de Vries P, Popp-Snijders C, van der Veen E 1995 The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J Clin Endocrinol Metab 80:2069-2076.
26. Leeuwenkamp OR, van der Vijgh WJF, Hüsken BCP, Lips P, Netelenbos JC 1990 Human pharmacokinetics of orally administered strontium. Calcif Tissue Int 47:136-141.
27. Teerlink T, Tavenier P, Netelenbos JC 1989 Selective determination of hydroxyproline in urine by high-performance liquid chromatography using precolumn derivatization. Clin Chimica Acta 183:309-316.
28. Mosekilde L, Heriksen EF, Charles P 1990 Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35-63.
29. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD 1994 Markers of bone turnover in hyperthyroidism and the effect of treatment. J Clin Endocrinol Metab 78:955-959.
30. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP 1991 The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 72:382-386.
31. Zetissen PMJ, Croughs RJM, van Rijk PP, Raymakers JA 1994 Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addisson disease. Ann Intern Med 120:207-210.
32. Canalis E 1996 Mechanisms of glucocorticoid action in bone: Implications of glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447.
33. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ 1989 Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523-527.
34. Orwoll ES, Klein RF 1995 Osteoporosis in men. Endocr Rev 16:87-116.
35. Brown DJ, Spanos E, Maclntire I 1980 Role of pituitary hormones in regulating renal vitamin D metabolism in man. Br Med J i:277-278.
36. Lund B, Eskildsen PC, Lund B, Norman AW, Sorensen OH 1981 Calcium and vitamin D metabolism in acromegaly. Acta Endocrinol 96:444-450.
37. Bijlsma JWJ, Nortier JWR, Duursma SA, Croughs RJM, Bosch R, Thijssen JHH 1983 Changes in bone metabolism during treatment of acromegaly. Acta Endocrinol 104:153-159.
38. Takamoto S, Tsuchiya H, Onishi T, Morimoto S, Imanaka S, Mori S, Seino Y, Uozumi T, Kumahara Y 1985 Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J Clin Endocrinol Metab 61:7-11.
39. 3 synthesis by phosphate deprivation: Evidence for a role for growth hormone. Endocrinology 116:189-193.
40. Halloran BP, Spencer EM 1988 Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: Influence of insulin-like growth factor I. Endocrinology 123:1225-1229.
41. Harbison MD, Gertner JM 1990 Permissive action of growth hormone on the renal response to dietary phosphorus deprivation. J Clin Endocrinol Metab 70:1035-1040.
42. Brixen K, Nielsen HK, Bouillon R, Flyvbjerg A, Mosekilde L 1992 Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon. Acta Endocrinol 127:331-336.
43. Burstein S, Chen IW, Tsang RC 1983 Effects of growth hormone replacement therapy on 1,25-dihydroxyvitamin D and calcium metabolism. J Clin Endocrinol Metab 56:1246-1251.
44. Francis RM, Peacock M, Aaron JE, Selby PL, Taylor GA, Thompson J, Marshall DH, Horsman A 1986 Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 7:261-268.